Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2007 pay falls 27% to $1.3M
Cyclacel Pharmaceuticals reports 2007 executive compensation
By ExecPay News
Published: April 2, 2008
Cyclacel Pharmaceuticals reported fiscal year 2007 executive compensation information on April 2, 2008.
In 2007, five executives at Cyclacel Pharmaceuticals received on average a compensation package of $818K, a 1% increase compared to previous year.
Average pay of disclosed executives at Cyclacel Pharmaceuticals
Spiro Rombotis, Chief Executive Officer, received $1.3M in total, which decreased by 27% compared to 2006. 56% of Rombotis' compensation, or $750K, was in option awards. Rombotis also received $137K in bonus, $425K in salary, as well as $21K in other compensation.
Paul McBarron, Chief Operating Officer, received a compensation package of $828K, which decreased by 29% compared to previous year. 45% of the compensation package, or $375K, was in option awards.
Judy Chiao, Vice President Clinical Development and Regulatory Affairs, earned $756K in 2007, a 22% decrease compared to previous year.
Greg Reyes, Senior Vice President Research, received $664K in 2007.
John F. Womelsdorf, Vice President, Business Development, earned $511K in 2007, a 25% decrease compared to previous year.
Related executives
Spiro Rombotis
Cyclacel Pharmaceuticals
Chief Executive Officer
Paul McBarron
Cyclacel Pharmaceuticals
Chief Financial Officer
Greg Reyes
Cyclacel Pharmaceuticals
Senior Vice President Research
Judy Chiao
Cyclacel Pharmaceuticals
Vice President, Clinical Development and Regulatory Affairs
John Womelsdorf
Cyclacel Pharmaceuticals
Vice President, Business Development
You may also like
Source: SEC filing on April 2, 2008.